Raymond James Financial’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
Other funds holding TYRA
SL
Raymond James Financial's TYRA Position: Q3 2026 in Review
Raymond James Financial reduced its Tyra Biosciences (TYRA) stake by 5.6% in Q3 2026, selling an estimated $276K and leaving 170,831 shares worth $3.74M. The position accounts for ﹤0.01% of the portfolio, ranked #3008.
Raymond James Financial first reported a position in TYRA in Q4 2024 and has held it in 8 quarters since. The position peaked at $9.46M in Q1 2026. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.
- Raymond James Financial held 170,831 shares of Tyra Biosciences worth $3.74M as of Q3 2026.
- Raymond James Financial sold 10,050 Tyra Biosciences shares in Q3 2026, an estimated $276K.
- Tyra Biosciences made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #3008 holding.
- Raymond James Financial first reported a position in Tyra Biosciences in Q4 2024 and has held it in 8 quarters since.
- Raymond James Financial's Tyra Biosciences position peaked at $9.46M in Q1 2026.
- 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.